S.A.S. DRAGON (01184) released its interim results, with shareholders' profit totaling HKD 812 million, an increase of 208.3% year-on-year.

19:07 20/08/2026

S.A.S. DRAGON (01184) announced its mid-year results for 2026, with revenue of approximately HKD 33.311 billion, an increase of 164.5% year-on-year; profit attributable to owners of the company reached HKD 812 million, an increase of 208.3% year-on-year; basic earnings per share were HKD 1.298, with an interim dividend of HKD 0.40 per share.

S.A.S. DRAGON (01184) announced its mid-term results for 2026, with revenue of approximately HKD 33.311 billion, an increase of 164.5% year-on-year; profit attributable to the owners of the company was HKD 812 million, up 208.3% year-on-year; basic earnings per share were HKD 1.298, and the interim dividend per share was HKD 0.40.

XINGFA ALUM (00098) issues profit warning, expecting the mid-term net profit attributable to shareholders to decrease year-on-year to between 165 million and 171 million yuan.

GENSCRIPT BIO (01548) issued 1.129 million shares as a result of stock options being exercised.

LI AUTO-W (02015) repurchased 936,000 shares at a cost of $5.9298 million on August 19.

XINGFA ALUM (00098) issues profit warning, expecting the mid-term net profit attributable to shareholders to decrease year-on-year to between 165 million and 171 million yuan.

GENSCRIPT BIO (01548) issued 1.129 million shares as a result of stock options being exercised.

LI AUTO-W (02015) repurchased 936,000 shares at a cost of $5.9298 million on August 19.